Pluripotent Reprogramming of Human AML Resets Leukemic Behavior and Models Therapeutic Targeting of Subclones

Mark P. Chao(Stanford Medicine), Ravindra Majeti(Stanford University), Rahul Singha(California Institute for Regenerative Medicine), Andreas Reinisch(Stem Cell Institute), M. Gerstein Rachel(California Institute for Regenerative Medicine), Joseph C. Wu(Cardiovascular Institute of the South), Marius Wernig(Stanford University), Susmita Chatterjee(California Institute for Regenerative Medicine), Jinfeng Shen(California Institute for Regenerative Medicine), M. Ryan Corces(Gladstone Institutes), Daniel Haag(California Institute for Regenerative Medicine), G Vasiliev Andrew(California Institute for Regenerative Medicine)
Blood
December 2, 2016
10.1182/blood.v128.22.575.575
Cited by 0

Related Papers

A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells
|Cell|2006|5.4k
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
|Nature|2007|4.2k
An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
|Nature Methods|2017|2.8k
Genome-scale DNA methylation maps of pluripotent and differentiated cells
|Nature|2008|2.5k
A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression
|Nature|2011|2k